Hung David, President and CEO, made three open market purchases of Nuvation Bio Inc. ($NUVB) shares totaling $1.7 million over the last year, with the most recent on June 16, 2025. This ranks him 358th among 4,983 insiders, above the average of $1.5 million per buyer and 3.29 transactions. He also sold NovoCure Ltd. ($NVCR) shares once for $17,300 on June 3, 2025, ranking 11,104th among 11,678 insiders with sales averaging $8.6 million across 6.37 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Nuvation Bio Inc. | $NUVB | Hung David | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 1995012 | $0.00 | 1,995,012.0000 | 342,833,433 | 9999.99% | 0.58% |
| June 16, 2025 | Nuvation Bio Inc. | $NUVB | Hung David | PRESIDENT AND CEO | P | Class A Common Stock | 500000 | $1.79 | 59,281,054.0000 | 337,678,855 | 0.85% | 0.15% |
| June 4, 2025 | NovoCure Ltd | $NVCR | Hung David | Not found | A | Ordinary Shares | 11215 | $0.00 | 23,410.0000 | 109,915,429 | 91.96% | 0.01% |
| June 4, 2025 | NovoCure Ltd | $NVCR | Hung David | Not found | A | Stock Option (Right to Buy) | 16697 | $0.00 | 16,697.0000 | 109,915,429 | 9999.99% | 0.02% |
| June 3, 2025 | NovoCure Ltd | $NVCR | Hung David | Not found | S | Ordinary Shares | 999 | $17.30 | 12,195.0000 | 109,915,429 | 7.57% | 0.00% |
| April 4, 2025 | Nuvation Bio Inc. | $NUVB | Hung David | PRESIDENT AND CEO | P | Class A Common Stock | 200000 | $1.66 | 58,481,054.0000 | 337,678,855 | 0.34% | 0.06% |
| April 7, 2025 | Nuvation Bio Inc. | $NUVB | Hung David | PRESIDENT AND CEO | P | Class A Common Stock | 300000 | $1.63 | 58,781,054.0000 | 337,678,855 | 0.51% | 0.09% |
| Feb. 28, 2025 | Nuvation Bio Inc. | $NUVB | Hung David | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | NovoCure Ltd | $NVCR | Hung David | Not found | A | Stock Option (Right to Buy) | 6229 | $0.00 | 6,229.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | NovoCure Ltd | $NVCR | Hung David | Not found | A | Restricted Stock Units | 4053 | $0.00 | 13,194.0000 | 0 | 44.34% | 0.00% |
| Feb. 29, 2024 | Nuvation Bio Inc. | $NUVB | Hung David | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | NovoCure Ltd | $NVCR | Hung David | Not found | A | Stock Option (Right to Buy) | 12554 | $0.00 | 12,554.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2021 | Nuvation Bio Inc. | $NUVB | Hung David | President and CEO | J | Class A Common Stock | 368408 | $0.00 | 58,281,054.0000 | 0 | 0.63% | 0.00% |
| Feb. 28, 2023 | Nuvation Bio Inc. | $NUVB | Hung David | President and CEO | A | Stock Option (Right to Buy) | 2500000 | $0.00 | 2,500,000.0000 | 0 | 9999.99% | 0.00% |